Opus Genetics, Inc. · NASDAQ:IRD

Foundation Fighting Blindness Retinal Degeneration Fund sold 1,700,000 Opus Genetics, Inc. shares (Form 4)

Traded May 18, 2026 · Filed May 20, 2026

On May 18, 2026, Foundation Fighting Blindness Retinal Degeneration Fund (Director, See Remarks) sold 1,700,000 Opus Genetics, Inc. shares at US$4.35 for US$7.39M, leaving 3,792,171 shares. Filed May 20, 2026 (Form 4).

Sold
1,700,000 shares
Price
US$4.35
Value
US$7.39M
Holding after
3,792,171 shares
Trading plan
No
Role
Director, See Remarks

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 18, 2026Common StockSale1,700,000US$4.353,792,171Direct

Source

View original at SEC

Related